References
- Alban J. Treatment of β-hemolytic streptococcal infection. Amer J Dis Child 1965; 109: 304
- Alfthan O., Liewendahl K., Ervast H. S. Clinical investigations showing the importance of temperature for diagnosis of sulfonamide crystalluria in man. Ann Clin Res 1969; 1: 177
- Biamonte A. R., Schneller G. H. Observations on the solubility of certain sulfonamides. J Amer Pharm Ass 1952; 41: 341
- Bratton A. C., Marshall E. K. A new coupling component for sulfanilamide determination. J Biol Chem 1939; 128: 537
- Elia J. C. New sulfonamide therapy for respiratory tract infections. Eye Ear Nose Throat Monthly 1962; 41: 722
- Krüger-Thiemer D., Bünger P. Evaluation of the risk of crystalluria with sulpha drugs. Proc Europ Soc for Study of Drug Tox 1965; 6: 185
- Reber H., Wild F., Paris J. Experimentel Daten über das neue Sulfonamide 5-Methyl-3-sulfanilamido-isoxazol (Ro 4–2130) beim Erwachsenen. Chemotherapia (Basel) 1963; 6: 273